Unknown

Dataset Information

0

D,L-Methadone causes leukemic cell apoptosis via an OPRM1-triggered increase in IP3R-mediated ER Ca2+ release and decrease in Ca2+ efflux, elevating [Ca2+]i.


ABSTRACT: The search continues for improved therapy for acute lymphoblastic leukemia (aLL), the most common malignancy in children. Recently, D,L-methadone was put forth as sensitizer for aLL chemotherapy. However, the specific target of D,L-methadone in leukemic cells and the mechanism by which it induces leukemic cell apoptosis remain to be defined. Here, we demonstrate that D,L-methadone induces leukemic cell apoptosis through activation of the mu1 subtype of opioid receptors (OPRM1). D,L-Methadone evokes IP3R-mediated ER Ca2+ release that is inhibited by OPRM1 loss. In addition, the rate of Ca2+ extrusion following D,L-methadone treatment is reduced, but is accelerated by loss of OPRM1. These D,L-methadone effects cause a lethal rise in [Ca2+]i that is again inhibited by OPRM1 loss, which then prevents D,L-methadone-induced apoptosis that is associated with activation of calpain-1, truncation of Bid, cytochrome C release, and proteolysis of caspase-3/12. Chelating intracellular Ca2+ with BAPTA-AM reverses D,L-methadone-induced apoptosis, establishing a link between the rise in [Ca2+]i and D,L-methadone-induced apoptosis. Altogether, our findings point to OPRM1 as a specific target of D,L-methadone in leukemic cells, and that OPRM1 activation by D,L-methadone disrupts IP3R-mediated ER Ca2+ release and rate of Ca2+ efflux, causing a rise in [Ca2+]i that upregulates the calpain-1-Bid-cytochrome C-caspase-3/12 apoptotic pathway.

SUBMITTER: Lee J 

PROVIDER: S-EPMC7806773 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

D,L-Methadone causes leukemic cell apoptosis via an OPRM1-triggered increase in IP3R-mediated ER Ca<sup>2+</sup> release and decrease in Ca<sup>2+</sup> efflux, elevating [Ca<sup>2+</sup>]<sub>i</sub>.

Lee JungKwon J   Rosales Jesusa L JL   Byun Hee-Guk HG   Lee Ki-Young KY  

Scientific reports 20210113 1


The search continues for improved therapy for acute lymphoblastic leukemia (aLL), the most common malignancy in children. Recently, D,L-methadone was put forth as sensitizer for aLL chemotherapy. However, the specific target of D,L-methadone in leukemic cells and the mechanism by which it induces leukemic cell apoptosis remain to be defined. Here, we demonstrate that D,L-methadone induces leukemic cell apoptosis through activation of the mu1 subtype of opioid receptors (OPRM1). D,L-Methadone evo  ...[more]

Similar Datasets

| S-EPMC7526510 | biostudies-literature
| S-EPMC6226504 | biostudies-literature
| S-EPMC10320280 | biostudies-literature
| S-EPMC11022737 | biostudies-literature
| S-EPMC9555318 | biostudies-literature
| S-EPMC10227063 | biostudies-literature
| S-EPMC5598166 | biostudies-literature
| S-EPMC6423007 | biostudies-literature
| S-EPMC9989825 | biostudies-literature
| S-EPMC4823145 | biostudies-literature